Cargando…
Sclerotherapy of Intraoral Superficial Hemangioma
Hemangioma is the clinical term for a benign vascular neoplasm due to proliferation of the endothelial lining of blood vessels. Their most frequent location is the body skin and oral mucosa. One of the treatment modalities for hemangiomas is intralesional injection of sclerosing agents which cause t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141317/ https://www.ncbi.nlm.nih.gov/pubmed/27994889 http://dx.doi.org/10.1155/2016/4320102 |
_version_ | 1782472587743330304 |
---|---|
author | Ademi Abdyli, Resmije Abdyli, Yll Perjuci, Feriall Gashi, Ali Agani, Zana Ahmedi, Jehona |
author_facet | Ademi Abdyli, Resmije Abdyli, Yll Perjuci, Feriall Gashi, Ali Agani, Zana Ahmedi, Jehona |
author_sort | Ademi Abdyli, Resmije |
collection | PubMed |
description | Hemangioma is the clinical term for a benign vascular neoplasm due to proliferation of the endothelial lining of blood vessels. Their most frequent location is the body skin and oral mucosa. One of the treatment modalities for hemangiomas is intralesional injection of sclerosing agents which cause the damage of blood vessels followed by their obliteration. The objective of the study was to describe the facility of application and evaluate the efficiency of sclerotherapy with aethoxysklerol 1%. Method. The case presented with intraoral submucosal hemangioma of the cheek was treated by intralesional injection of aethoxysklerol 3% diluted in water for injections at a 4 : 1 ratio (0.75%) at the first appointment and 3 : 1 (1%) at the second appointment. The effect of sclerotherapy was evaluated on the following visits in time intervals of two weeks. Results. The hemangioma disappeared without complications after the second injection of aethoxysklerol 1%. The successful results of the study were comparable to the data of literature with variations according to the used sclerosant agent, its concentration, the number of injections, and the intervals between each session. Conclusion. Since sclerotherapy is a very effective, inexpensive, and easy-to-apply treatment, it should be the treatment of choice, especially for intraoral superficial hemangiomas. |
format | Online Article Text |
id | pubmed-5141317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-51413172016-12-19 Sclerotherapy of Intraoral Superficial Hemangioma Ademi Abdyli, Resmije Abdyli, Yll Perjuci, Feriall Gashi, Ali Agani, Zana Ahmedi, Jehona Case Rep Dent Case Report Hemangioma is the clinical term for a benign vascular neoplasm due to proliferation of the endothelial lining of blood vessels. Their most frequent location is the body skin and oral mucosa. One of the treatment modalities for hemangiomas is intralesional injection of sclerosing agents which cause the damage of blood vessels followed by their obliteration. The objective of the study was to describe the facility of application and evaluate the efficiency of sclerotherapy with aethoxysklerol 1%. Method. The case presented with intraoral submucosal hemangioma of the cheek was treated by intralesional injection of aethoxysklerol 3% diluted in water for injections at a 4 : 1 ratio (0.75%) at the first appointment and 3 : 1 (1%) at the second appointment. The effect of sclerotherapy was evaluated on the following visits in time intervals of two weeks. Results. The hemangioma disappeared without complications after the second injection of aethoxysklerol 1%. The successful results of the study were comparable to the data of literature with variations according to the used sclerosant agent, its concentration, the number of injections, and the intervals between each session. Conclusion. Since sclerotherapy is a very effective, inexpensive, and easy-to-apply treatment, it should be the treatment of choice, especially for intraoral superficial hemangiomas. Hindawi Publishing Corporation 2016 2016-11-23 /pmc/articles/PMC5141317/ /pubmed/27994889 http://dx.doi.org/10.1155/2016/4320102 Text en Copyright © 2016 Resmije Ademi Abdyli et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ademi Abdyli, Resmije Abdyli, Yll Perjuci, Feriall Gashi, Ali Agani, Zana Ahmedi, Jehona Sclerotherapy of Intraoral Superficial Hemangioma |
title | Sclerotherapy of Intraoral Superficial Hemangioma |
title_full | Sclerotherapy of Intraoral Superficial Hemangioma |
title_fullStr | Sclerotherapy of Intraoral Superficial Hemangioma |
title_full_unstemmed | Sclerotherapy of Intraoral Superficial Hemangioma |
title_short | Sclerotherapy of Intraoral Superficial Hemangioma |
title_sort | sclerotherapy of intraoral superficial hemangioma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141317/ https://www.ncbi.nlm.nih.gov/pubmed/27994889 http://dx.doi.org/10.1155/2016/4320102 |
work_keys_str_mv | AT ademiabdyliresmije sclerotherapyofintraoralsuperficialhemangioma AT abdyliyll sclerotherapyofintraoralsuperficialhemangioma AT perjuciferiall sclerotherapyofintraoralsuperficialhemangioma AT gashiali sclerotherapyofintraoralsuperficialhemangioma AT aganizana sclerotherapyofintraoralsuperficialhemangioma AT ahmedijehona sclerotherapyofintraoralsuperficialhemangioma |